Short answer
Bausch Health Companies Inc (BHC) filed an 8-K current report with the SEC on July 1, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure). Michael Goettler resigning from Bausch Health’s Board effective June 30, 2026.
Bausch Health Companies Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Michael Goettler resigning from Bausch Health’s Board effective June 30, 2026
- Departure tied to his appointment as President and CEO of Knoa Pharma LLC
- No disagreement with Bausch Health’s operations, policies or practices reported
- Board composition change without disclosed strategic or governance conflict
Item 7.01 · Regulation FD Disclosure
- Press release announces Mr. Goettler’s resignation, signaling a senior leadership transition
- Investor focus: successor appointment, timing, and potential strategy or execution impact
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Bausch Health Companies Inc 8-K filings
Get the next BHC 8-K as it lands
Follow BHC for push alerts, or ask the research agent what this filing means.